Logo 1117 Logo 1117 (Diltiazem Hydrochloride Extended-Release 420 mg)
Pill with imprint Logo 1117 Logo 1117 is Gray, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release 420 mg. It is supplied by Actavis Elizabeth LLC.
Diltiazem is used in the treatment of atrial fibrillation; atrial flutter; heart failure; angina pectoris prophylaxis; high blood pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 420 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 1117 Logo 1117

Diltiazem Hydrochloride Extended-Release
- Imprint
- Logo 1117 Logo 1117
- Strength
- 420 mg
- Color
- Gray
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Elizabeth LLC
- National Drug Code (NDC)
- 00228-1117 (Discontinued)
- Inactive Ingredients
-
methacrylic acid - methyl methacrylate copolymer (1:1),
methacrylic acid - methyl methacrylate copolymer (1:2),
silicon dioxide,
gelatin,
hydroxypropyl cellulose,
polyethylene glycol,
sodium lauryl sulfate,
sucrose,
corn starch,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
More about diltiazem
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (161)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: calcium channel blocking agents
Patient resources
- Drug Information
- Diltiazem (Advanced Reading)
- Diltiazem Intravenous (Advanced Reading)
- Diltiazem Long-Acting Tablets
- Diltiazem 12-Hour Sustained-Release Capsules
- Other brands
- Cardizem, Cartia XT, Dilt-XR, Tiazac, ... +7 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.